Author Details

Agulnik, J., Jewish General Hospital, Canada

  • Vol 23, No 2 (2016) - Letter to the Editor
    Response to: Second-line treatment of non-small-cell lung cancer with wild-type EGFR status. What is the best approach?
    Abstract  PDF  HTML